NYSE$AVNS
Avanos Medical Inc · Q1 2024 earnings
Q1 2024 earnings · · Investor relations
Briefing
AVNS Q1 2024 — $16.9M revenue, 0.02 EPS
The matters discussed in these forward-looking statements are based on the current plans and expectations of our management and are subject to certain risks and uncertainties that could cause actual r. Avanos Medical Inc reported Q1 2024 results. Diluted EPS came in at $0.02. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Revenue: $16.9M.
- Diluted EPS: $0.02.
- Operating income: $6.1M.
- Gross profit: $94.8.
Headline financials
Revenue & EPS history
Avanos · Revenue · Quarterly
$166M
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2024
-0.7%
Avg return
Earnings day
-1.1%
Avg return
5 days after
-1.7%
Avg return
30 days after
50%
25 / 50 earnings
Positive
+17.2%
Q3 2023
Best reaction
-27.6%
Q3 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.1% | +0.5% | +1.3% | |
| Q4 2025 | -11.0% | -7.4% | -9.1% | |
| Q3 2025 | -1.2% | -3.3% | +1.4% | |
| Q1 2025 | +5.6% | +3.8% | +1.1% | |
| Q4 2024 | +0.4% | -2.8% | -10.3% | |
| Q3 2024 | -17.5% | -15.1% | -15.3% | |
| Q2 2024 | +3.4% | -0.0% | +5.5% | |
| Q1 2024 | +4.7% | +4.0% | +6.0% | |
| Q4 2023 | +1.7% | +2.6% | +1.6% | |
| Q3 2023 | +17.2% | +18.3% | +20.3% | |
| Q2 2023 | -2.1% | -5.8% | -15.4% | |
| Q1 2023 | -18.7% | -19.0% | -14.3% | |
| Q4 2022 | -2.7% | -4.3% | -6.5% | |
| Q3 2022 | -0.1% | +7.2% | +20.9% | |
| Q2 2022 | -1.3% | +1.8% | -13.4% | |
| Q1 2022 | +0.9% | -12.0% | -3.8% | |
| Q4 2021 | +15.1% | +19.9% | +12.2% | |
| Q3 2021 | +12.8% | +9.7% | -4.6% | |
| Q2 2021 | -11.8% | -9.8% | -12.5% | |
| Q1 2021 | -8.2% | -10.0% | -8.6% | |
| Q4 2020 | -14.7% | -16.7% | -14.0% | |
| Q3 2020 | +9.2% | +7.2% | +17.4% | |
| Q2 2020 | -0.8% | +0.0% | +3.1% | |
| Q1 2020 | -4.2% | -6.3% | +10.0% | |
| Q4 2019 | +7.3% | +5.9% | -16.4% | |
| Q3 2019 | -27.6% | -24.9% | -30.4% | |
| Q2 2019 | -3.5% | +0.7% | -10.4% | |
| Q1 2019 | -6.3% | -3.8% | -13.8% | |
| Q4 2018 | -6.7% | -6.2% | -18.4% | |
| Q3 2018 | -15.5% | -13.8% | -21.9% | |
| Q2 2018 | +9.8% | +8.0% | +23.4% | |
| Q1 2018 | +8.0% | +9.6% | +15.9% | |
| Q4 2017 | +2.3% | -3.2% | -4.5% | |
| Q3 2017 | +11.5% | +9.9% | +14.9% | |
| Q2 2017 | +6.6% | +6.5% | +13.6% | |
| Q1 2017 | -7.0% | -5.0% | -6.5% | |
| Q4 2016 | -5.7% | -3.0% | -7.7% | |
| Q3 2016 | +0.7% | +6.6% | +16.4% | |
| Q2 2016 | +5.6% | +6.4% | +8.1% | |
| Q1 2016 | -2.2% | — | — | |
| Q4 2015 | +1.7% | — | — | |
| Q3 2015 | +4.6% | — | — | |
| Q2 2015 | -1.1% | — | — | |
| Q1 2014 | -2.4% | — | — | |
| Q1 2015 | +2.2% | — | — | |
| Q2 2014 | -0.3% | — | — | |
| Q4 2012 | -0.3% | — | — | |
| Q4 2014 | +3.7% | — | — | |
| Q3 2014 | +0.7% | — | — | |
| Q4 2013 | +0.7% | — | — | |
| Q3 2013 | — | — | — | |
| Q2 2013 | — | — | — | |
| Q1 2013 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro